Literature DB >> 24497569

Comment on Ferroni et al.: "Impact of chemotherapy on venous thromboembolism.: Comment to: Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study" HAEMATOL/2012/073338 and HAEMATOL/2013/092528.

Boris Dickmann1, Jonas Ahlbrecht, Cihan Ay, Ingrid Pabinger.   

Abstract

Entities:  

Keywords:  Vienna Cancer and Thrombosis Study; cancer; distant stage; local stage; regional stage; venous thromboembolism

Mesh：

Year:  2014        PMID： 24497569      PMCID： PMC3912983          DOI： 10.3324/haematol.2013.101477

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.

Authors:  Patrizia Ferroni; Silvia Riondino; Fiorella Guadagni; Mario Roselli
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

2.  High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

Authors:  R Simanek; R Vormittag; C Ay; G Alguel; D Dunkler; I Schwarzinger; G Steger; U Jaeger; C Zielinski; I Pabinger
Journal:  J Thromb Haemost       Date:  2009-11-02       Impact factor: 5.824

3.  Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.

Authors:  Richard H White; Helen K Chew; Hong Zhou; Arti Parikh-Patel; David Harris; Danielle Harvey; Theodore Wun
Journal:  Arch Intern Med       Date:  2005 Aug 8-22

4.  Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study.

Authors:  Cihan Ay; Daniela Dunkler; Ralph Simanek; Johannes Thaler; Silvia Koder; Christine Marosi; Christoph Zielinski; Ingrid Pabinger
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

5.  Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.

Authors:  Boris Dickmann; Jonas Ahlbrecht; Cihan Ay; Daniela Dunkler; Johannes Thaler; Werner Scheithauer; Peter Quehenberger; Christoph Zielinski; Ingrid Pabinger
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

6.  High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.

Authors:  R Vormittag; R Simanek; C Ay; D Dunkler; P Quehenberger; C Marosi; C Zielinski; I Pabinger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-24       Impact factor: 8.311

7.  Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.

Authors:  Jonas Ahlbrecht; Boris Dickmann; Cihan Ay; Daniela Dunkler; Johannes Thaler; Manuela Schmidinger; Peter Quehenberger; Andrea Haitel; Christoph Zielinski; Ingrid Pabinger
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

8.  D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.

Authors:  Cihan Ay; Rainer Vormittag; Daniela Dunkler; Ralph Simanek; Alexandru-Laurentiu Chiriac; Johannes Drach; Peter Quehenberger; Oswald Wagner; Christoph Zielinski; Ingrid Pabinger
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

9.  Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence.

Authors:  Mario Roselli; Patrizia Ferroni; Silvia Riondino; Sabrina Mariotti; Anastasia Laudisi; Matteo Vergati; Francesco Cavaliere; Raffaele Palmirotta; Fiorella Guadagni
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

Review 10.  Assessing risk of venous thromboembolism in the patient with cancer.

Authors:  Alok A Khorana; Gregory C Connolly
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.